Summary
Estrogen is involved in both normal mammary development and in breast carcinogenesis. A family history of disease and exposure to estrogen are major risk factors for developing breast cancer. Estrogen exerts its biological effects through binding to the estrogen receptors, estrogen receptor alpha (ESR1) and the more recently discovered estrogen receptor beta (ESR2). Genetic variation in genes involved in estrogen biosynthesis, metabolism and signal transduction have been suggested to play a role in breast cancer risk. We therefore tested the hypothesis that common genetic variants of the ESR2 gene may be associated with increased risk for breast cancer and this risk may vary between breast cancer groups. We investigated three common ESR2 polymorphisms, rs1256049 (G1082A), rs4986938 (G1730A) and rs928554 (Cx+56 A→G) for association to breast cancer risk. A total of 723 breast cancer cases and 480 controls were included in the study. Of the breast cancer cases, 323 were sporadic and 400 were familial, the familial cases were further divided into familial high-risk and familial low-risk breast cancer cases. We found no overall statistically significant association for any of the single polymorphisms studied. Haplotype analysis suggested one haplotype associated with increased risk in sporadic breast cancer patients (OR = 3.0, p = 0.03). Further analysis is needed to elucidate the role of estrogen receptor beta in breast cancer susceptibility.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Y Miki J Swensen D Shattuck-Eidens PA Futreal K Harshman S Tavtigian Q Liu C Cochran LM Bennett W Ding (1994) ArticleTitleA strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66–71 Occurrence Handle7545954
R Wooster SL Neuhausen J Mangion Y Quirk D Ford N Collins K Nguyen S Seal T Tran D Averill (1994) ArticleTitleLocalization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13 Science 265 2088–2090 Occurrence Handle8091231
PD Pharoah A Antoniou M Bobrow RL Zimmern DF Easton BA Ponder (2002) ArticleTitlePolygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 33–36 Occurrence Handle10.1038/ng853 Occurrence Handle11984562
AM Martin BL Weber (2000) ArticleTitleGenetic and hormonal risk factors in breast cancer J Natl Cancer Inst 92 1126–1135 Occurrence Handle10.1093/jnci/92.14.1126 Occurrence Handle10904085
S Green P Walter V Kumar A Krust JM Bornert P Argos P Chambon (1986) ArticleTitleHuman oestrogen receptor cDNA: sequence, expression and homology to v-erb-A Nature 320 134–139 Occurrence Handle10.1038/320134a0 Occurrence Handle3754034
GL Greene P Gilna M Waterfield A Baker Y Hort J Shine (1986) ArticleTitleSequence and expression of human estrogen receptor complementary DNA Science 231 1150–1154 Occurrence Handle3753802
S Mosselman J Polman R Dijkema (1996) ArticleTitleER beta: identification and characterization of a novel human estrogen receptor FEBS Lett 392 49–53 Occurrence Handle10.1016/0014-5793(96)00782-X Occurrence Handle8769313
GG Kuiper E Enmark M Pelto-Huikko S Nilsson JA Gustafsson (1996) ArticleTitleCloning of a novel receptor expressed in rat prostate and ovary Proc Natl Acad Sci USA 93 5925–5930 Occurrence Handle10.1073/pnas.93.12.5925 Occurrence Handle8650195
QX Zhang A Borg SA Fuqua (1993) ArticleTitleAn exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer Cancer Res 53 5882–5884 Occurrence Handle8261397
S Inoue S Hoshino H Miyoshi M Akishita T Hosoi H Orimo Y Ouchi (1996) ArticleTitleIdentification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells Biochem Biophys Res Commun 219 766–772 Occurrence Handle10.1006/bbrc.1996.0308 Occurrence Handle8645255
S Ogawa S Inoue T Watanabe A Orimo T Hosoi Y Ouchi M Muramatsu (1998) ArticleTitleMolecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human Nucleic Acids Res 26 3505–3512 Occurrence Handle10.1093/nar/26.15.3505 Occurrence Handle9671811
S Ogawa S Inoue T Watanabe H Hiroi A Orimo T Hosoi Y Ouchi M Muramatsu (1998) ArticleTitleThe complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro Biochem Biophys Res Commun 243 122–126 Occurrence Handle10.1006/bbrc.1997.7893 Occurrence Handle9473491
E Leygue H Dotzlaw PH Watson LC Murphy (1999) ArticleTitleExpression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue Cancer Res 59 1175–1179 Occurrence Handle10096542
C Palmieri GJ Cheng S Saji M Zelada-Hedman A Warri Z Weihua S Noorden ParticleVan T Wahlstrom RC Coombes M Warner (2002) ArticleTitleEstrogen receptor beta in breast cancer Endocr Relat Cancer 9 1–13 Occurrence Handle10.1677/erc.0.0090001 Occurrence Handle11914179
K Iwao Y Miyoshi C Egawa N Ikeda S Noguchi (2000) ArticleTitleQuantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancers Int J Cancer 88 733–736 Occurrence Handle10.1002/1097-0215(20001201)88:5<733::AID-IJC8>3.0.CO;2-M Occurrence Handle11072241
C Zhao EW Lam A Sunters E Enmark MT Bella ParticleDe RC Coombes JA Gustafsson K Dahlman-Wright (2003) ArticleTitleExpression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation Oncogene 22 7600–7606 Occurrence Handle10.1038/sj.onc.1207100 Occurrence Handle14576822
E Leygue H Dotzlaw PH Watson LC Murphy (1998) ArticleTitleAltered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis Cancer Res 58 3197–3201 Occurrence Handle9699641
AM Dunning CS Healey PD Pharoah MD Teare BA Ponder DF Easton (1999) ArticleTitleA systematic review of genetic polymorphisms and breast cancer risk Cancer Epidemiol Biomarkers Prev 8 843–854 Occurrence Handle10548311
A Forsti C Zhao E Israelsson K Dahlman-Wright JA Gustafsson K Hemminki (2003) ArticleTitlePolymorphisms in the estrogen receptor beta gene and risk of breast cancer: no association Breast Cancer Res Treat 79 409–413 Occurrence Handle10.1023/A:1024020609833 Occurrence Handle12846425
SL Zheng W Zheng BL Chang XO Shu Q Cai H Yu Q Dai J Xu YT Gao (2003) ArticleTitleJoint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women Cancer Res 63 7624–7629 Occurrence Handle14633679
B Gold F Kalush J Bergeron K Scott N Mitra K Wilson N Ellis H Huang M Chen R Lippert (2004) ArticleTitleEstrogen receptor genotypes and haplotypes associated with breast cancer risk Cancer Res 64 8891–8900 Occurrence Handle10.1158/0008-5472.CAN-04-1256 Occurrence Handle15604249
K Rosenkranz A Hinney A Ziegler H Hermann M Fichter H Mayer W Siegfried JK Young H Remschmidt J Hebebrand (1998) ArticleTitleSystematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants J Clin Endocrinol Metab 83 4524–4527 Occurrence Handle10.1210/jc.83.12.4524 Occurrence Handle9851804
M Nilsson S Naessen I Dahlman A Linden Hirschberg JA Gustafsson K Dahlman-Wright (2004) ArticleTitleAssociation of estrogen receptor beta gene polymorphisms with bulimic disease in women Mol Psychiatry 9 28–34 Occurrence Handle10.1038/sj.mp.4001402 Occurrence Handle14699439
EB Claus JM Schildkraut WD Thompson NJ Risch (1996) ArticleTitleThe genetic attributable risk of breast and ovarian cancer Cancer 77 2318–2324 Occurrence Handle10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z Occurrence Handle8635102
MH Gail LA Brinton DP Byar DK Corle SB Green C Schairer JJ Mulvihill (1989) ArticleTitleProjecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 1879–1886 Occurrence Handle2593165
S Margolin B Werelius T Fornander A Lindblom (2004) ArticleTitleBRCA1 mutations in a population-based study of breast cancer in Stockholm County Genet Test 8 127–132 Occurrence Handle15345109
JC Barrett B Fry J Maller MJ Daly (2005) ArticleTitleHaploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 263–265 Occurrence Handle10.1093/bioinformatics/bth457 Occurrence Handle15297300
F Dudbridge (2003) ArticleTitlePedigree disequilibrium tests for multilocus haplotypes Genet Epidemiol 25 115–121 Occurrence Handle10.1002/gepi.10252 Occurrence Handle12916020
SB Gabriel SF Schaffner H Nguyen JM Moore J Roy B Blumenstiel J Higgins M DeFelice A Lochner M Faggart (2002) ArticleTitleThe structure of haplotype blocks in the human genome Science 296 2225–2229 Occurrence Handle10.1126/science.1069424 Occurrence Handle12029063
S Inoue S Ogawa K Horie S Hoshino W Goto T Hosoi O Tsutsumi M Muramatsu Y Ouchi (2000) ArticleTitleAn estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbeta Biochem Biophys Res Commun 279 814–819 Occurrence Handle10.1006/bbrc.2000.4010 Occurrence Handle11162434
D Tong E Schuster M Seifert K Czerwenka S Leodolte R Zeillinger (2002) ArticleTitleExpression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines Breast Cancer Res Treat 71 249–255 Occurrence Handle10.1023/A:1014465916473 Occurrence Handle12002343
Y Omoto S Kobayashi S Inoue S Ogawa T Toyama H Yamashita M Muramatsu JA Gustafsson H Iwase (2002) ArticleTitleEvaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers Eur J Cancer 38 380–386 Occurrence Handle10.1016/S0959-8049(01)00383-5 Occurrence Handle11818203
I Poola J Abraham A Liu (2002) ArticleTitleEstrogen receptor beta splice variant mRNAs are differentially altered during breast carcinogenesis J Steroid Biochem Mol Biol 82 169–179 Occurrence Handle10.1016/S0960-0760(02)00185-1 Occurrence Handle12477483
C Palmieri S Saji H Sakaguchi G Cheng A Sunters MJ O’Hare M Warner JA Gustafsson RC Coombes EW Lam (2004) ArticleTitleThe expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts J Mol Endocrinol 33 35–50 Occurrence Handle10.1677/jme.0.0330035 Occurrence Handle15291741
I Girault C Andrieu S Tozlu F Spyratos I Bieche R Lidereau (2004) ArticleTitleAltered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma Cancer Lett 215 101–112 Occurrence Handle10.1016/j.canlet.2004.05.006 Occurrence Handle15374639
C Sundarrajan WX Liao AC Roy SC Ng (2001) ArticleTitleAssociation between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disorders J Clin Endocrinol Metab 86 135–139 Occurrence Handle10.1210/jc.86.1.135 Occurrence Handle11231990
S Ogawa T Hosoi M Shiraki H Orimo M Emi M Muramatsu Y Ouchi S Inoue (2000) ArticleTitleAssociation of estrogen receptor beta gene polymorphism with bone mineral density Biochem Biophys Res Commun 269 537–541 Occurrence Handle10.1006/bbrc.2000.2285 Occurrence Handle10708589
Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, Vivo ID: Estrogen receptor beta (ESR2) polymorphisms and endometrial cancer (United States) Cancer Causes Control 15: 627–633, 2004
S Garte L Gaspari AK Alexandrie C Ambrosone H Autrup JL Autrup H Baranova L Bathum S Benhamou P Boffetta (2001) ArticleTitleMetabolic gene polymorphism frequencies in control populations Cancer Epidemiol Biomarkers Prev 10 1239–1248 Occurrence Handle11751440
K Hemminki A Forsti (2002) ArticleTitleProper controls for SNP studies? Carcinogenesis 23 1405–1406 Occurrence Handle10.1093/carcin/23.8.1405 Occurrence Handle12151361
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maguire, P., Margolin, S., Skoglund, J. et al. Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer. Breast Cancer Res Treat 94, 145–152 (2005). https://doi.org/10.1007/s10549-005-7697-7
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-7697-7